참고문헌 (15)

1. Scott, K.P., Antoine, J-M., Midtvedt, T., Hemert, S.V., Manipulating the gut microbiota to maintain health and treat disease. Microb. Ecol. Health Dis., 26 (2015). 

2. Kerry, G.R., Patra, J.K., Gouda, S., Park, Y., Shin, H.S, Das, G., Benefaction of probiotics for human health: A review. J. Food Drug Anal., 26, 927-939 (2018). 

   상세보기

3. Chon, J.W., Seo, K.H., Bae, D.Y., Jeong, D.K., Song, K.Y., Status and Prospect of Lactic Acid Bacteria with Antibiotic Resistance. J. Dairy Sci. Biotechnol., 38, 70-88 (2020). 

4. Yasmin, I., Saeed, M., Khan, W.A., Khaliq, A., Chughtai, M., Iqbal, R., Tehseen, S., Naz, S., Liaqat, A., Mehmood, T., Ahsan, S., Tanweer, S., In vitro probiotic potential and safety evaluation (Hemolytic, Cytotoxic Activity) of Bifidobacterium strains isolated from raw camel milk., Microorganism. 8, 354 (2020). 

5. National Institute of Food and Drug Safety Evaluation, (2019). Guide to preparation of sub-mission data for recognition of functional ingredients for health supplements. Retrieved from https://www.nifds.go.kr/brd/m_15/view.do?seq12803&srchFr&srchTo&srchWord%EA%B8%B0%EB%8A%A5%EC%84%B1%26nbsp%EC%9B%90%EB%A3%8C&srchTp0&itm_seq_20&multi_itm_seq0&company_cd&company_nm&page1. 

6. Cyril, S., Stulberg, Ph.D., Wolf, W., Zuelzer, M.D., Anthony, C., Nolke, M.D., Escherichia Coli O127:B8, a Pathogenic Strain Causing Infantile Diarrhea. AMA Am. J. Dis. Child., 90(2), 125-134 (1995). 

7. Seo, Y.G., Yoon, Y.H., Kim, S.J., Functionality and Safety of Probiotics. J. Dairy Sci. Biotechnol., 37, 94-101 (2019). 

8. Alcock, B.P., Raphenya, A.R., Lau, T., Tsang, K.K., Bouchard, M., Edalatmand, A., Huynh, W., Nguyen, A.V., Cheng, A.A., Liu, S., Min, S.Y., Miroshnichenko, A., Tran, H.K., Werfalli, R.E., Nasir, J.A., Oloni, M., Speicher, D.J., Florescu, A., Singh, B., Faltyn, M., Hernandez-Koutoucheva, A., Sharma, A.N., Bordeleau, E., Pawlowski, A.C., Zubyk, H.L., Dooley, D., Griffiths, E., Maguire, F., Winsor, G.L., Beiko, R.G., Brinkman, F.S.L., Hsiao, W.W.L., Domselaar, G.V., McArthur, A.G., CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res., 48, D517-D525 (2020). 

9. Jia, B., Raphenya, A.R., Alcock, B., Waglechner, N., Guo, P., Tsang, K.K., Lago, B.A., Dave, B.M., Pereira, S., Sharma, A. N., Doshi, S., Courtot, M., Lo, R., Williams, L.E., Frye, J.G., Elsayegh, T., Sardar, D., Westman, E.L., Pawlowski, A.C., Johnson, T.A., Brinkman, F.S.L., Wright, G.D., McArthur, A. G., CARD 2017: expansion and model-centric curation of the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res., 45, D566-D573 (2017). 

   상세보기

10. Fotakis, G., Timberll, J.A., In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett., 160, 171-177 (2005). 

11. European Food Safety Authority (EFSA)., Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA Journal., 10, 2740 (2012). 

12. Kiwaki, M., Sato, T., Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int. J. Food Microbiol., 134, 211-215 (2009). 

    상세보기

13. Comprehensive Antibiotic Resistance Database (CARD version 3.0.4). Mycobacterium tuberculosis rpsL mutations conferring resistance to streptomycin. Retrieved from http://card.mcmaster.ca/ontology/39979 

14. Comprehensive Antibiotic Resistance Database (CARD version 3.0.4). Tet (W/N/W). http://card.mcmaster.ca/ontology/41634 

15. Duranti, S., Lugli, G.A., Mancabelli, L., Turroni, F., Milani, C., Mangifesta, M., Ferrario, C., Anzalone, R., Viappiani, A., van Sinderen, D., Ventura, M., Prevalence of Antibiotic Resistance Genes among Human Gut-Derived Bifidobacteria. Appl. Environ. Microbiol., 83, e02894-16 (2017). 

    상세보기